CLOV vs IMCR · rev $1.37B vs rev $310.2M
Clover Health Investments Corp (CLOV) versus Immunocore Holdings Ltd (IMCR) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IMCR revenue for 2024-12-31 was $310.2M. Net income was -$51.1M. Revenue was up 24.4% from 2023-12-31 to 2024-12-31. IMCR currently screens at market cap $1.45B.
CLOV currently screens at market cap $1.55B. IMCR currently screens at market cap $1.45B.
Not investment advice. Open the CLOV and IMCR stock pages for the full models.
Not investment advice.